Amanat Holdings PJSC (AMANT.DU)

Also known as:  Amanat, Amanat Holdings
Data delayed by 15 minutes
0.885 AED 0.000.00%
As of 12 DEC 2019 09:55 GMT|Dubai FM

Amanat Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.695%
P/E (Last 12 Month)
42.55
Upside
-
Target Price (Mean)
-
52Wk
0.802 13 NOV
1.15 02 JAN

Open
Data not available
Previous Close
0.885 AED
Turnover
Data not available
EPS
0.021 AED
Volume
0
Transactions
0
Market Cap
2.21B AED
IPO Date
30-Nov-2014
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Amanat Holdings PJSCLast updated on: 25 January 2019

Business Summary
Provides direct investments in the healthcare and education sectors.
Country of Incorporation
Ownership Type
Established In
2014
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
AMANAT.DFMOrdinaryAEDDubai FMAMANAT

Contact details

Primary address
Emirates Towers Office Building
Sheikh Zayed Road
30th Floor
121012
UAE
Dubai
CONTACT
Region
Dubai

Wednesday outlook: Oil prices drop 5 percent overnight

Oil prices dropped close to 5 percent on Tuesday, regained some ground on Wednesday. Asian shares traded lower on Wednesday following a retreat on Wall Street overnight. More commentary on Middle East markets, currencies and precious metals

ZAWYA - 24 Oct 2018
All Related News

Amanat Holdings appoints liquidity provider

The purpose of this agreement is to enhance the liquidity of Amanat shares and support shareholder value by reducing the impact of volatility and improve trading parameters for existing and potential investors

Press Release - 20 Nov 2019

Amanat Holdings records 43% growth in Net Profit in Q1 2019

Net Profit in Q1 2019 stood at AED 20.7 million, a 43% increase compared to Q1 2018 as benefits of the AED1.2 Billion deployed in 4 portfolio companies show through. Excluding the Royal Hospital for Women & Children which was only recently opened and still ramping up, Amanat would have recorded an 56% growth in its Net Profit in Q1 2019 compared to Q1 2018

Press Release - 12 May 2019
All Press Releases
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Tristan De Boysson
Chief Executive Officer
Dr Shamsheer Vayalil Parambath
Managing Director
Mr Daoud Mohammed Daoud Al Ghoul
Chief Financial Officer

Board Members

HE Hamad Abdullah Rashid Al Obeid Al Shamsi
Chairman
Dr Shamsheer Vayalil Parambath
Vice Chairman
HE Faisal Bin Juma Khalfan Belhoul Al Falasi
Director
All People

Company information provided by © 2019 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
GULF PHARM IND0.850 AED0.00
GULF MEDICAL1.500 AED0.00
All Peers
Morning Briefing

Sunday Outlook: Shares gain, oil rises on Sino-U.S. deal report

Sunday Outlook: Shares gain, oil rises on Sino-U.S. deal report

Oil nears 3-month high as trade hopes, UK election boost sentiment

Read More

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks